dc1 vaccine
Vaccineexperimental
Clinical trial activity
2 trials · 3 clinical orgs · 0 marketing orgs
Phase 1
0
Phase 2
2
Phase 3
0
Phase 4
0
Earliest trial started Sep 1, 2009 (NCT00970203)
Timeline
2000s
- Jan 1, 2009
Earliest Phase 2 Sponsor(trial)
Indications
Mechanism of action
- Tumor antigensImmunity, active
immunity, active - tumor antigen
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Also known as
- dc1 vaccine
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT03384914 | Phase 2 | Feb 9, 2018 | Department of Defense, University of South Florida |
| NCT00970203 | Phase 2 | Sep 1, 2009 | University of Pittsburgh |
Showing 2 of 2 trials
Page 1 / 1
Organizations
Research & Development (3)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Department of Defense | Government | 1 | 0 | 1 | 2018 |
| University of Pittsburgh | Academic/Hospital | 1 | 1 | 1 | 2009 |
| University of South Florida | Academic/Hospital | 1 | 1 | 1 | 2018 |
3 organizations
Page 1 / 1